Gynecology & Obstetrics (all articles)
RCT | Effect of second-stage pushing timing on postpartum pelvic floor morbidity
30 Jan, 2023 | 00:31h | UTCEffect of Second-Stage Pushing Timing on Postpartum Pelvic Floor Morbidity: A Randomized Controlled Trial – Obstetrics & Gynecology (free for a limited period)
Commentary on Twitter
How does timing of pushing in obstetrics impact future pelvic floor health? #freearticle https://t.co/VPZgVt8JnU pic.twitter.com/gSiTGN1Vdv
— The Green Journal (@greenjrnl) January 24, 2023
M-A | Permanent compared with absorbable suture in apical prolapse surgery
30 Jan, 2023 | 00:29h | UTCPermanent Compared With Absorbable Suture in Apical Prolapse Surgery: A Systematic Review and Meta-analysis – Obstetrics & Gynecology (free for a limited period)
Commentary on Twitter
Should you use permanent or absorbable suture for apical prolapse? https://t.co/G8nkMQgUQV pic.twitter.com/LwBwyS1WV8
— The Green Journal (@greenjrnl) January 27, 2023
Cohort Study | Incidence and impact of anticoagulation-associated abnormal menstrual bleeding after VTE
27 Jan, 2023 | 12:04h | UTCInvited Commentary: The burden of heavy menstrual bleeding – Blood
Commentary on Twitter
Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism https://t.co/IEftFzyvRl pic.twitter.com/m09sP14inN
— Blood Journal (@BloodJournal) October 26, 2022
Perspective | Endocrine treatment for 5 years or radiation for 5 days for patients with early breast cancer older than 65 years
26 Jan, 2023 | 12:04h | UTC
Commentary from the author on Twitter
?Hot off the press @JCO_ASCO: For decades we have been offering RT omission for early #bcsm patients, here we discuss how tides have changed and its time to omit hormonal therapy and treat with RT instead @TaghianAlphonse @MGHBreastOnc @LurieCancer
— George E. Naoum, MD, MMSCI (@George_E_Naoum) December 20, 2022
European guidelines on perinatal care: corticosteroids for women at risk of preterm birth
25 Jan, 2023 | 11:32h | UTC
RCT | Breast-cancer–related lymphedema after reverse lymphatic mapping and selective axillary dissection vs. standard surgical treatment of axilla
24 Jan, 2023 | 14:15h | UTC
Commentary on Twitter
New & available #OpenAccess | Occurrence of breast-cancer–related #lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two-arm randomized clinical trial https://t.co/fXB7PfysCH @OncoAlert pic.twitter.com/wWNhC9BMvY
— ACS Journal Cancer (@JournalCancer) October 20, 2022
Meta-analysis reaffirms benefits of O-RADS MRI for diagnosing indeterminate adnexal lesions
24 Jan, 2023 | 14:05h | UTCOriginal Study: O-RADS MRI: A Systematic Review and Meta-Analysis of Diagnostic Performance and Category-wise Malignancy Rates – Radiology (link to abstract – $ for full-text)
Commentary on Twitter
A meta-analysis of 4520 adnexal lesions from 12 studies showed that MRI O-RADS has a 92% summary sensitivity and a 91% summary specificity in characterizing lesions that are indeterminate at US. https://t.co/WSJVQUiM4T pic.twitter.com/kssAK2s02N
— Radiology (@radiology_rsna) November 23, 2022
RCT | Routine use of endometrial receptivity testing to guide the timing of frozen embryo transfer did not improve the rates of live birth
20 Jan, 2023 | 14:45h | UTCEffect of Timing by Endometrial Receptivity Testing vs Standard Timing of Frozen Embryo Transfer on Live Birth in Patients Undergoing In Vitro Fertilization: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)
Commentary on Twitter
Study findings do not support routine use of receptivity testing to guide the timing of embryo transfer during in vitro fertilization. https://t.co/p8jqTpRAfV #Research
— JAMA (@JAMA_current) December 6, 2022
Gestational age at birth and cognitive outcomes in adolescence: population based full sibling cohort study
19 Jan, 2023 | 14:27h | UTCEditorial: Gestational age at birth and school performance – The BMJ
News Release: Premature birth linked to poorer school grades in adolescence – BMJ
Cohort Study | Neurodevelopmental disorders in offspring conceived via IVF vs. intracytoplasmic sperm injection
19 Jan, 2023 | 14:12h | UTC
Review | Advances in the diagnosis and early management of gestational trophoblastic disease
19 Jan, 2023 | 14:08h | UTCAdvances in the diagnosis and early management of gestational trophoblastic disease – BMJ Medicine
Review | An FP’s guide to identifying—and treating—postpartum depression
19 Jan, 2023 | 13:56h | UTCAn FP’s guide to identifying—and treating—postpartum depression – Journal of Family Practice
Review | Surgical site infection prevention
18 Jan, 2023 | 14:31h | UTCSurgical Site Infection Prevention: A Review – JAMA (free for a limited period)
Author interview: Surgical Site Infection Prevention – JAMA
Related:
Global guidelines on the prevention of surgical site infection – World Health Organization
AAOS Guideline: Prevention of surgical site infections after major extremity trauma.
M-A | Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection
18 Jan, 2023 | 14:27h | UTCNews Release: COVID-19 infection at any time during pregnancy boosts mother’s risk of death – BMJ
Commentary: Getting COVID in Pregnancy Greatly Raises a Woman’s Odds for Death – HealthDay
Cohort Study | Proton pump inhibitors are unlikely to be major teratogens during pregnancy
18 Jan, 2023 | 14:14h | UTC
Commentary on Twitter
This large nationwide cohort study of 2.7 million pregnancies suggested that maternal proton pump inhibitor use during pregnancy is not associated with an increased risk of congenital malformations. https://t.co/fvgthhIYa7
— JAMA Network Open (@JAMANetworkOpen) January 10, 2023
Cohort Study | Safety and effects of buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
18 Jan, 2023 | 14:10h | UTCCommentary: Buprenorphine-Naloxone Appears Safe for Maternal Opioid Use Disorder – HealthDay
Review | Computerized cardiotocography analysis during labor
18 Jan, 2023 | 14:09h | UTC
SR | Outcomes and management of pregnancy and puerperal group A streptococcal infections
18 Jan, 2023 | 14:08h | UTC
Review | Current perspectives on maternity critical care
17 Jan, 2023 | 13:00h | UTCCurrent perspectives on maternity critical care – Anaesthesia
Cohort Study | Contralateral breast cancer risk among carriers of germline pathogenic variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2
13 Jan, 2023 | 13:14h | UTC
RCT | Planned delivery for pre-eclampsia between 34 and 37 weeks of gestation
12 Jan, 2023 | 13:20h | UTCOriginal Publication: Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial – The Lancet
RCT | Effect of pessary vs. surgery in patients with symptomatic pelvic organ prolapse
12 Jan, 2023 | 13:16h | UTCEffect of Pessary vs Surgery on Patient-Reported Improvement in Patients With Symptomatic Pelvic Organ Prolapse: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)
Commentary: Findings question value of pessary for pelvic organ prolapse – MDedge
Commentary on Twitter
In this study, among patients with symptomatic pelvic organ prolapse, an initial strategy of pessary therapy, compared with surgery, did not meet criteria for noninferiority with regard to patient-reported improvement at 24 months. https://t.co/PRb7iclR8O pic.twitter.com/ex3SSmLqyz
— JAMA (@JAMA_current) December 20, 2022
SR | No-test medication abortion
10 Jan, 2023 | 14:02h | UTCNo-Test Medication Abortion: A Systematic Review – Obstetrics & Gynecology
Commentary on Twitter
From Shapiro et al: medication abortion performed without prior pelvic exam or ultrasound is safe and effective. #free #podcast https://t.co/xightukWW0 pic.twitter.com/P6bajuKZDU
— The Green Journal (@greenjrnl) December 21, 2022
WHO updates recommendations on HPV vaccination schedule
9 Jan, 2023 | 14:57h | UTCNews Release: WHO updates recommendations on HPV vaccination schedule – World Health Organization
Guideline: Human papillomavirus vaccines: WHO position paper, December 2022 – World Health Organization
Commentaries:
WHO supports 1-dose HPV vaccine strategy – CIDRAP
Commentary on Twitter
? WHO has revised its recommendations on possible schedules for human papillomavirus (#HPV) vaccines & now recommends:
?1 or 2-doses for girls & women aged 9-20
?2 doses with a 6-month interval for women 21+https://t.co/m0KZyH6sPR pic.twitter.com/W4PeS4raV9— World Health Organization (WHO) (@WHO) December 21, 2022
Review | Transmission of Group B Streptococcus in late-onset neonatal disease
9 Jan, 2023 | 14:05h | UTC